Unusual presentation of central nervous system manifestations of Varicella zoster virus vasculopathy in renal transplant recipients

Transplant Infectious Disease

Volumn 9, Issue 3, 2007, Pages 237-240

  Hovens, M M C ^a   Vaessen, N ^a   Sijpkens, Y W J ^a   De Fijter, J W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CNS; CSF; Immunocompromised; Renal transplant recipient; Varicella zoster; Vasculopathy

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMOXICILLIN; BASILIXIMAB; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; VALACICLOVIR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS;

ADULT; CENTRAL NERVOUS SYSTEM INFECTIONS; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MIDDLE AGED; VASCULAR DISEASES;

EID: 34547800672     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00190.x     Document Type: Article

References (20)

1. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004 4: 108 115.
2. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000 342: 635 645.
3. Gilden DH. Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J Neurol Sci 2002 195: 99 101.
4. Kalpoe JS, Kroes AC, Verkerk S, Claas EC, Barge RM, Beersma MF. Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation. Bone Marrow Transplant 2006 38: 41 46.
5. Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000 38: 712 715.
6. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med 2001 125: 770 780.
7. Hilt DC, Buchholz D, Krumholz A, Weiss H, Wolinsky JS. Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol 1983 14: 543 553.
8. Ahmad NM, Boruchoff SE. Multiple cerebral infarcts due to varicella-zoster virus large-vessel vasculopathy in an immunocompetent adult without skin involvement. Clin Infect Dis 2003 37: e16 e18.
9. Russman AN, Lederman RJ, Calabrese LH, Embi PJ, Forghani B, Gilden DH. Multifocal varicella-zoster virus vasculopathy without rash. Arch Neurol 2003 60: 1607 1609.
10. Koskiniemi M, Piiparinen H, Rantalaiho T, et al. Acute central nervous system complications in varicella zoster virus infections. J Clin Virol 2002 25: 293 301.
11. Picard O, Brunereau L, Pelosse B, Kerob D, Cabane J, Imbert JC. Cerebral infarction associated with vasculitis due to varicella zoster virus in patients infected with the human immunodeficiency virus. Biomed Pharmacother 1997 51: 449 454.
12. Hutchinson P, Jose M, Atkins RC, Holdsworth SR. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment. Transpl Immunol 2004 13: 55 61.
13. Lauzurica R, Bayes B, Frias C, et al. Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc 2003 35: 1758 1759.
14. Fehr T, Bossart W, Wahl C, Binswanger U. Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature. Transplantation 2002 73: 608 611.
15. Smak Gregoor PJ, van Gelder T, van Riemsdijk-van Overbeeke IC, Vossen AC, IJzermans JN, Weimar W. Unusual presentation of herpes virus infections in renal transplant recipients exposed to high mycophenolic acid plasma concentrations. Transpl Infect Dis 2003 5: 79 83.
16. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin corticosteroids for prevention of acute rejection. Lancet 1995 345: 1321 1325.
17. US Renal Mycophenolate mofetil in cadaveric renal transplantation. Transplant Mycophenolate Mofetil Study Group. Am J Kidney Dis 1999 34: 296 303.
18. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996 61: 1029 1037.
19. Boivin G. Diagnosis of herpesvirus infections of the central nervous system. Herpes 2004 11 (Suppl. 2): 48A 56A.
20. Davies NW, Brown LJ, Gonde J, et al. Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections. J Neurol Neurosurg Psychiatry 2005 76: 82 87.